Presbyopia market to grow at 4.9% CAGR by 2036, driven by aging population and new treatments.

The global presbyopia market is projected to grow at a compound annual growth rate (CAGR) of 4.9% from 2026 to 2036, fueled by the increasing aging population and rising prevalence of near vision impairment. Market expansion is supported by greater awareness, improved diagnosis, and the introduction of innovative therapies and devices such as Phentolamine, MicroLine, and CorVision. The U.S. leads the market with half of the global share, and new pharmacological treatments like VUITY and QLOSI are gaining regulatory approvals. Emerging treatments are expected to transform the market landscape, offering better patient outcomes and expanding treatment options.